Study identifier:BY9010/M1-506
ClinicalTrials.gov identifier:NCT00314509
EudraCT identifier:N/A
CTIS identifier:N/A
ADVICE: A dose range finding study of formoterol administered once daily in the evening in combination with ciclesonide using the Ultrahaler™ versus monotherapy of each drug in asthmatic patients
asthma
Phase 2
No
Ciclesonide/Formoterol Combination
All
240
Interventional
18 Years - 75 Years
Allocation: Randomized
Endpoint Classification: None
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Dec 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|